Davut Güven

Davut Güven

Auto-generated profile, based on publicly available information

Davut Güven

Faculty of Medicine, Gynecology and Obstetrics, Ondokuz Mayis University, Samsun, Turkey

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Toxicology Research
Verified
Journal Article
Open access
PDF file
YDYavuz Kursad Das
Yavuz Kursad Das
DGDavut Guven
Davut Guven
DGDilek Guvenç
Dilek Guvenç
OTOrhan Tokur
Orhan Tokur
AAAbdurrahman Aksoy
Abdurrahman Aksoy
In this study, the levels of a group of organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCBs) in the adipose tissue of women living in northern Turkey who gave birth by cesarean delivery were investigated.

27 March 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
SBSümeyye BAL
Sümeyye BAL
NKNeşe Karakaya
Neşe Karakaya
EKEmine Koç
Emine Koç
DGDavut Güven
Davut Güven
Intrauterine insemination (IUI) also found that this experience was associated with anxiety. Therefore, measures must be taken to reduce or eliminate the pain and anxiety associated with it. This study investigated the effect of virtual reality glasses (VRG) and therapeutic touch (TT) on pain, anxiety and satisfaction during intrauterine insemination. A single blind randomized controlled trial design was used. Patients were randomized into three groups: the virtual reality group (VRG, n = 32), the therapeutic touch group (TT, n = 32), and the control group (CG, n = 32). The study was conducted between January and June 2022 in the obstetric outpatient clinics of a public hospital in northern Türkiye. Anxiety was evaluated using the State Anxiety Inventory. Pain, and satisfaction were evaluated using the Visual Analogue Scale [VAS]. “The study used non-parametric tests for its statistics.” There was a significant difference in the pain level of the VRG group during IUI was lower than those of CG 3.7 ± 2.7 and TT 3.6 ± 2.9 (p = 0.01). Women were most satisfied with the TT application 9.2 ± 1.1 in the IUI procedure (p = 0.000). Anxiety levels after IUI were lower in the TT 43.0 ± 4.2 and VRG 43.9 ± 4.4 than in CG 49.9 ± 4.0 (p = 0.000). VRG application was effective in reducing pain associated with IUI procedure in women. Although the use of VRG with music reduced the pain associated with IUI more than the TT application, the women left the TT application satisfied. The study was registered at the Clinical Trials.gov website under the code NCT05192330. The first trial registration date was (12/01/2022).

1 January 2022 in Journal of Experimental and Clinical Medicine
Verified
Journal Article
Closed access
YKYunus Katirci
Yunus Katirci
AÖAyşe Zehra ÖZDEMİR
Ayşe Zehra ÖZDEMİR
DGDavut Güven
Davut Güven
IKİdris Koçak
İdris Koçak
Uterovesical fistula is a rare complication. In this case, a utero-fetal fistula developed in a patient with lower uterine segment compression suture in cesarean section due to placenta previa totalis is described.

1 March 2019 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
AÖAyşe Zehra Özdemir
Ayşe Zehra Özdemir
BABülent Ayas
Bülent Ayas
DGDavut Güven
Davut Güven
ATAysun Türkmen
Aysun Türkmen
ÇGÇağrı Gülümser
Çağrı Gülümser
Objective: To compare the outcomes of antagonist stimulation protocols and to compare the cost effectiveness. Materials and Methods: Between 2011 and December 2017, a total of 354 women who underwent intracytoplasmic sperm injection and controlled ovarian stimulation with antagonist protocols were enrolled in the study. The antagonist implementation on the day of human chorionic gonadotropin (hCG) was continued for 194 of women, whereas the antagonist was stopped 36 hours before in 160 women. The stimulation outcomes of patients and cost-effectiveness of the regimens were compared. Results: There was a significant difference between the groups in terms of number of cryopreserved embryos, mature/immature oocyte ratio, and embryo transfer cancellations (p<0.05). The median value for the mature/immature oocyte ratio was 1.1 (0.2-7.5) and 1 (0.5-15) (p=0.001), and the ET cancellation was 5.3% vs. 1% for group 1 and 2, respectively (p=0.037). There was no difference between the groups in terms of pregnancy rates (p=0.197). Conclusion: No difference was found in the clinical pregnancy rates between the two groups. For this reason, the cessation of antagonist implementation on the day of hCG seems more advantageous in terms of cost-effectiveness and fewer injections.

18 March 2020 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
MKMehmet Ali Koçdor
Mehmet Ali Koçdor
EDErbil Doğan
Erbil Doğan
IKIşıl Kasapoğlu
Işıl Kasapoğlu
BGBahadır Güllüoğlu
Bahadır Güllüoğlu
DGDavut Güven
Davut Güven
MCMurat Celiloğlu
Murat Celiloğlu

6 September 2024 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
HUHasan Ulubaşoğlu
Hasan Ulubaşoğlu
KBKadir Bakay
Kadir Bakay
AYAli Yavuzcan
Ali Yavuzcan
DGDavut Güven
Davut Güven
ŞHŞafak Hatırnaz
Şafak Hatırnaz
Michael DahanMichael Dahan
Michael Dahan
Background: The purpose of this research is to compare the efficacy of 8% micronized vaginal progesterone gel (VAG) at 180 mg daily versus intramuscular progesterone (IMP) in oil at 100 mg daily for luteal phase support (LPS) after fresh single embryo transfer (SET) in Patient-Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) Group 1b patients, and to ascertain whether the type of LPS predicts live birth in these patients. Methods: A total of 2420 assisted reproductive technology (ART) cycles performed in Ondokuz Mayıs University IVF Unit were analysed retrospectively. The data of POSEIDON Group 1b (unexpected suboptimal responders) who underwent antagonist in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles were included. All patients were categorized into groups according to the form of LPS, specifically VAG and IMP. Pregnancy, clinical pregnancy rate (CPR), live birth rate (LBR), spontaneous abortion rate and predictors of live birth (age, infertility duration, body mass index (BMI), type of progesterone used for luteal support, serum day 3 estradiol, serum progesterone on the day of human coryonic gonadotrophin (HCG), total duration of induction, serum estradiol on the day of HCG, the total number of oocytes retrieved, number of mature oocytes obtained, average gonadotropin dose per day, total gonadotropin dose administered and total number of embryos retrieved) were analyzed. Results: There was no statistically significant difference between the micronized VAG and IMP groups in terms of age (31 (23–35) vs. 27 (23–35), p = 0.319). There were no statistically significant differences in pregnancy outcomes between the two groups concerning CPR per transfer (70.6% vs. 75.6%; p = 0.364), ongoing pregnancy per cycle (36.2% vs. 39.5%; p = 0.577), and LBR per cycle (34.4% vs. 36.1%; p = 0.785). The spontaneous abortion rates (36.2% vs. 36.8%; p = 0.921) were similar between VAG and IMP groups. The type of LPS did not emerge as a parameter predicting pregnancy (odds ratio (OR): 0.718, 95% confidence interval (95% CI): 0.652–1.313, p = 0.451), clinical pregnancy (OR: 0.598, 95% CI: 0.592–1.289, p = 0.562) and live birth (OR: 0.802, 95% CI: 0.661–1.202, p = 0.580). The logistic regression analysis aimed at assessing the influence of confounding factors, namely age, BMI, and duration of infertility on pregnancy rate, CPR and LBR, did not reveal statistically significant results (p > 0.05). Conclusions: VAG 180 mg daily provide similar pregnancy outcomes compared to 100 mg daily IMP in POSEIDON Group 1b patients undergoing antagonist fresh IVF/ICSI cycles.